U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
Contact Us FAQs Site Map About MedelinePlus
español
Reuters Health Information Logo

Influenza may trigger Guillain-Barre syndrome

Printer-friendly version E-mail this page to a friend

Reuters Health

Wednesday, January 28, 2009

NEW YORK (Reuters Health) - Influenza infection can occasionally precipitate the occurrence of Guillain-Barre syndrome, French researchers report in the journal Clinical Infectious Diseases.

Guillain-Barre syndrome is an inflammatory disease affecting the peripheral nerves, with symptoms of weakness, numbness or tingling in the arms and legs. Loss of movement and feeling in the arms, legs, upper body, and face may also occur.

The condition "is usually triggered by infectious disease or vaccine," senior investigator Dr. Elyanne Gault told Reuters Health. "To date, influenza was associated with Guillain-Barre syndrome through vaccination, based on the report of a high number of Guillain-Barre syndrome cases during a mass vaccination campaign against swine influenza in the US."

The current study reports "virological evidence that influenza infection is a trigger for Guillain-Barre syndrome, with a frequency related to the level of influenza epidemics," she explained.

Gault of Hopital Ambroise Pare, Boulogne-Billancourt, and colleagues studied data on 406 Guillain-Barre syndrome patients. The causative agent was unidentified in 234 patients.

The researchers investigated the monthly incidence of Guillain-Barre syndrome cases and the incidence of influenza-like illnesses, and also analyzed anti-influenza antibodies.

In all, 73 Guillain-Barre syndrome cases were positively link to influenza. Nearly 14 percent had serological evidence of recent influenza A infection and 5.5 percent had evidence of influenza B infection. Eight of the 10 influenza A cases occurred during a major influenza season and antibodies specific to the current epidemic strain were seen in 9 of these patients.

Gault concluded, "Although the occurrence is rare, it is by far more frequent than that following influenza vaccine...The benefit of large-scale influenza vaccination should also be considered as a means to protect against Guillain-Barre syndrome."

SOURCE: Clinical Infectious Diseases, January 1, 2009.


Reuters Health

Copyright © 2009 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Related News:
More News on this Date

Related MedlinePlus Pages: